Literature DB >> 28610886

Conversion From Off-Pump Coronary Artery Bypass Grafting to On-Pump Coronary Artery Bypass Grafting.

Brent Keeling1, Vinod Thourani2, Gorav Aliawadi3, Sunghee Kim4, Derek Cyr4, Vinay Badhwar5, Jeff P Jacobs6, J Matthew Brennan4, James Meza4, Roland Matsouaka4, Michael E Halkos2.   

Abstract

BACKGROUND: Off-pump coronary artery bypass grafting (OPCAB) has been shown to be an effective strategy for surgical revascularization. The purpose of this study was to define the incidence of intraoperative conversion from OPCAB to on-pump coronary artery bypass grafting (ONCAB) and report outcomes based on the reason for conversion.
METHODS: Starting in July 2007, the Society of Thoracic Surgeons database captured patients that were planned OPCAB but then were converted to ONCAB. A total of 196,576 patients undergoing planned OPCAB within the Society of Thoracic Surgeons National Database from July 2007 to June 2014 were evaluated. Patients were grouped according to their intraoperative conversion to cardiopulmonary bypass: (1) planned conversion, (2) unplanned conversion for visualization, (3) unplanned conversion for hemodynamic instability, and (4) no conversion (OPCAB). Multiple logistic regression analysis was used to determine risk factors for conversion.
RESULTS: The overall rate of conversion from OPCAB to ONCAB was 5.5%, with 49.6% of the conversions being planned. When compared with those not undergoing conversion (OPCAB, 30-day mortality observed to expected ratio [O/E], 0.8), those undergoing conversion to ONCAB experienced greater 30-day mortality regardless of etiology of conversion (planned conversion O/E, 1.4; unplanned conversion for visualization O/E, 1.6; and unplanned conversion for hemodynamic instability O/E, 2.7). Similar O/E ratios were observed for renal failure and prolonged ventilation following conversion. Logistic regression analysis showed advanced age, ejection fraction less than 35%, preoperative intraaortic balloon pump placement, increasing number of diseased coronary arteries, preoperative heart failure within 2 weeks, and urgent procedural status were all independent predictors for conversion to ONCAB (p ≤ 0.01).
CONCLUSIONS: Intraoperative conversion from OPCAB to ONCAB remains a morbid event with a risk of mortality much higher than expected. Surgeons should consider elective ONCAB in those with a high risk for conversion during OPCAB.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28610886     DOI: 10.1016/j.athoracsur.2017.03.032

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

1.  Early and Medium Outcomes of On-Pump Beating-Heart versus Off-Pump CABG in Patients with Moderate Left Ventricular Dysfunction.

Authors:  Weitie Wang; Yong Wang; Hulin Piao; Bo Li; Tiance Wang; Dan Li; Zhicheng Zhu; Rihao Xu; Kexiang Liu
Journal:  Braz J Cardiovasc Surg       Date:  2019 Jan-Feb

Review 2.  Perioperative Information Systems: Opportunities to Improve Delivery of Care and Clinical Outcomes in Cardiac and Vascular Surgery.

Authors:  Robert E Freundlich; Jesse M Ehrenfeld
Journal:  J Cardiothorac Vasc Anesth       Date:  2017-11-04       Impact factor: 2.628

3.  Off-Pump Coronary Artery Bypass Grafting: Department of Veteran Affairs' Use and Outcomes.

Authors:  Salil V Deo; Yakov Elgudin; A Laurie W Shroyer; Salah Altarabsheh; Vikas Sharma; Joseph Rubelowsky; Lorraine Cornwell; Piroze Davierwala; Danny Chu; Brian Cmolik
Journal:  J Am Heart Assoc       Date:  2022-03-01       Impact factor: 6.106

4.  Hemodynamic Changes During Heart Displacement in Aorta No-Touch Off-Pump Coronary Artery Bypass Surgery: A Pilot Study.

Authors:  Alexandre R Carvalho; Solange Guizilini; Gustavo M Murai; Isis Begot; Isadora S Rocco; Nelson A Hossne; Eduardo G Chamlian; João Manoel T Santos; Ricardo A Macedo; Gustavo C O Lisboa; Alberto C Nasciutti; Carlos Eduardo R Santos; João Paulo M Figueiredo; Walter J Gomes
Journal:  Braz J Cardiovasc Surg       Date:  2018 Sep-Oct

5.  Effects of Minimal Extracorporeal Circulation on the Systemic Inflammatory Response and the Need for Transfusion after Coronary Bypass Grafting Surgery.

Authors:  Mehmet Emre Elçi; Aydın Kahraman; Emre Mutlu; Cemil Selim İspir
Journal:  Cardiol Res Pract       Date:  2019-06-04       Impact factor: 1.866

6.  Comprehensive Study of Different Expressed Genes and Their Functional Modules in Anesthesia for Off-Pump Coronary Artery Bypass Grafting.

Authors:  Hui Zhou; Wang Min; Zhihua Zhu
Journal:  Biomed Res Int       Date:  2020-07-04       Impact factor: 3.411

Review 7.  Off-Pump Coronary Artery Bypass Grafting: 30 Years of Debate.

Authors:  Mario Gaudino; Gianni D Angelini; Charalambos Antoniades; Faisal Bakaeen; Umberto Benedetto; Antonio M Calafiore; Antonino Di Franco; Michele Di Mauro; Stephen E Fremes; Leonard N Girardi; David Glineur; Juan Grau; Guo-Wei He; Carlo Patrono; John D Puskas; Marc Ruel; Thomas A Schwann; Derrick Y Tam; James Tatoulis; Robert Tranbaugh; Michael Vallely; Marco A Zenati; Michael Mack; David P Taggart
Journal:  J Am Heart Assoc       Date:  2018-08-21       Impact factor: 5.501

8.  Conversion during off-pump coronary artery bypass graft surgery: A case-control study.

Authors:  Murali Chakravarthy; Dattatreya Prabhakumar; T A Patil; Antony George; Vivek Jawali
Journal:  Ann Card Anaesth       Date:  2019 Jan-Mar

9.  Conversion from Off to On-Pump Coronary Artery Bypass Grafting. Is it Avoidable?

Authors:  Khuzaima Tariq; Kashif Zia; Ali Mangi; Muneer Amanullah; Pervaiz A Chaudry; Musa Karim
Journal:  Cureus       Date:  2020-01-27

10.  Off- Versus On-Pump Coronary Surgery and the Effect of Follow-Up Length and Surgeons' Experience: A Meta-Analysis.

Authors:  Mario Gaudino; Umberto Benedetto; Faisal Bakaeen; Mohamed Rahouma; Derrick Y Tam; Ahmed Abouarab; Antonino Di Franco; Jeremy Leonard; Adham Elmously; John D Puskas; Gianni D Angelini; Leonard N Girardi; Stephen E Fremes; David P Taggart
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.